RNA·04965N104·US·equity-Activist
RNA (ATRIUM THERAPEUTICS INC) is held by 0 institutional investors as of Q1 2026. Largest holders: FARALLON CAPITAL MANAGEMENT LLC ($4.7M), CANTOR FITZGERALD, L. P. ($3.2M), TWO SIGMA INVESTMENTS, LP ($2.4M). Net institutional sentiment: Bearish.
See how RNA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer